(Q42589744)

3 November 2017

0 references

Adalimumab in the therapy of uveitis in childhood (English)

1 reference

3 November 2017

0 references

1 reference

Ahmad M Mansour

1

1 reference

PMC publication ID

1857669

3 November 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

British Journal of Ophthalmology

3 November 2017

1 reference

3 November 2017

91

1 reference

3 November 2017

3

1 reference

3 November 2017

274-276

1 reference

Adalimumab in the therapy of uveitis in childhood

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Optic neuritis associated with etanercept therapy for juvenile arthritis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Clinical pharmacokinetics of TNF antagonists: how do they differ?

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Differentiating the efficacy of tumor necrosis factor inhibitors.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Recent advances in uveitis of juvenile idiopathic arthritis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Use of tumor necrosis factor inhibitors in rheumatoid arthritis: a national survey of practicing United States rheumatologists.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Adalimumab-associated optic neuritis.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857669

Anti-TNF therapies in the management of acute and chronic uveitis

16 August 2018

1 reference

12 December 2020

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study

1 reference

12 December 2020

Adalimumab therapy for childhood uveitis

1 reference

12 December 2020

Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritis

1 reference

12 December 2020

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation

1 reference

12 December 2020

Infliximab treatment of posterior uveitis

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.2006.108050

1 reference

3 November 2017

1 reference

PMC publication ID

1857669

3 November 2017

PubMed publication ID

17322463

1 reference

PMC publication ID

1857669